Watson Pharmaceuticals, Inc. To Host Second Quarter 2004 Earnings Conference Call And Webcast
CORONA, Calif., July 19 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the Company intends to release its second quarter 2004 financial results on Tuesday, August 3, 2004 before the open of the trading day. The Company will also host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on that day to discuss the results and provide an outlook for the third quarter and full year 2004. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.
A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Daylight Time on August 8, 2004. The replay may be accessed by dialing (800) 642-1687 and entering pass code 8771485. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code. To access the webcast, go to Watson's Investor Relations Web site at http://ir.watsonpharm.com/. A replay of the webcast will also be available.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watsonpharm.com/.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.CONTACT: Investors, Patty Eisenhaur, +1-909-493-5611, or Media, ChrisEso, +1-909-493-4013, both of Watson Pharmaceuticals, Inc.